JD Rowley

6.3k total citations · 1 hit paper
78 papers, 5.1k citations indexed

About

JD Rowley is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, JD Rowley has authored 78 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hematology, 32 papers in Molecular Biology and 31 papers in Public Health, Environmental and Occupational Health. Recurrent topics in JD Rowley's work include Acute Myeloid Leukemia Research (55 papers), Acute Lymphoblastic Leukemia research (31 papers) and Chronic Myeloid Leukemia Treatments (27 papers). JD Rowley is often cited by papers focused on Acute Myeloid Leukemia Research (55 papers), Acute Lymphoblastic Leukemia research (31 papers) and Chronic Myeloid Leukemia Treatments (27 papers). JD Rowley collaborates with scholars based in United States, Japan and Australia. JD Rowley's co-authors include JW Vardiman, Richard A. Larson, MM Le Beau, HM Golomb, J Pedersen-Bjergaard, Giuseppina Nucifora, JR Testa, MO Diaz, CM Rubin and MA Bitter and has published in prestigious journals such as Blood and Leukemia.

In The Last Decade

JD Rowley

78 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease

1981 384 citations JD Rowley, HM Golomb et al. Blood profile →

Peers

Countries citing papers authored by JD Rowley

Since Specialization

Citations

This map shows the geographic impact of JD Rowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JD Rowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JD Rowley more than expected).

Fields of papers citing papers by JD Rowley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JD Rowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JD Rowley. The network helps show where JD Rowley may publish in the future.

Co-authorship network of co-authors of JD Rowley

This figure shows the co-authorship network connecting the top 25 collaborators of JD Rowley. A scholar is included among the top collaborators of JD Rowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JD Rowley. JD Rowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chromosomal instability in chromosome band 12p13: multiple breaks leading to complex rearrangements including cytogenetically undetectable sub-clones 2001 ·Leukemia ·Yuko Sato, Hirofumi Kobayashi, Yasushi Suto, (unknown), (unknown), (unknown), R Espinosa, MM Le Beau, JD Rowley	24
2	Molecular genetics in acute leukemia 2000 ·Leukemia ·JD Rowley	60
3	The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator 1997 ·Leukemia ·Jon Soderholm, Hirofumi Kobayashi, Chantal Mathieu, JD Rowley, Giuseppina Nucifora	81
4	Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia 1994 ·Blood ·David F. Claxton, (unknown), (unknown), Paula Marlton, J Hester, FS Collins, AB Deisseroth, JD Rowley, MJ Siciliano	8
5	Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission 1993 ·Blood ·Giuseppina Nucifora, Richard A. Larson, JD Rowley	224
6	Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridization. 1993 ·Blood ·Hirofumi Kobayashi, Rafael Espinosa, MJ Thirman, (unknown), (unknown), MO Diaz, MM Le Beau, JD Rowley	64
7	Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders 1992 ·Blood ·(unknown), CM Rubin, (unknown), Richard A. Larson, MM Le Beau, JD Rowley, JW Vardiman, (unknown), (unknown)	45
8	Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy 1991 ·Blood ·CM Rubin, DC Arthur, WG Woods, B Lange, PC Nowell, JD Rowley, James B. Nachman, Bruce Bostrom, (unknown), (unknown)	13
9	Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia 1987 ·Blood ·CM Rubin, Richard A. Larson, MA Bitter, (unknown), MM Le Beau, MO Diaz, JD Rowley	5
10	Evidence favoring lineage fidelity in acute nonlymphocytic leukemia: absence of immunoglobulin gene rearrangements in FAB types M4 and M5 1987 ·Blood ·(unknown), CA Westbrook, MO Diaz, MM Le Beau, JD Rowley	21
11	Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia 1987 ·Blood ·CM Rubin, Richard A. Larson, MA Bitter, (unknown), MM Le Beau, MO Diaz, JD Rowley	70
12	Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes 1986 ·Blood ·Jacobs Rh, (unknown), JW Vardiman, Richard A. Larson, MM Le Beau, JD Rowley	211
13	Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis 1986 ·Blood ·Richard A. Larson, SF Williams, MM Le Beau, MA Bitter, JW Vardiman, JD Rowley	8
14	Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia 1985 ·Blood ·MA Bitter, (unknown), MM Le Beau, (unknown), JD Rowley	147
15	Cytogenetic studies on patients with chronic T cell leukemia/lymphoma 1984 ·Blood ·(unknown), JD Rowley, (unknown), (unknown), (unknown)	4
16	Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease 1981 ·Blood ·JD Rowley, HM Golomb, JW Vardiman	24
17	Chromosome abnormalities in Down's syndrome patients with acute leukemia 1981 ·Blood ·(unknown), JD Rowley, (unknown), (unknown), (unknown), (unknown)	2
18	Chromosome abnormalities in Down's syndrome patients with acute leukemia 1981 ·Blood ·Yasuhiko Kaneko, JD Rowley, Daina Variakojis, (unknown), (unknown), (unknown)	51
19	Chronic myelodysplastic syndrome (preleukemia) with the Philadelphia chromosome 1980 ·Blood ·(unknown), (unknown), JD Rowley	2
20	Variant ph1 translocation in chronic myeloid leukemia [letter] 1979 ·Blood ·JD Rowley, (unknown), (unknown), (unknown), RT Silver	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact